Giulia Mauri | Medicine and Health Sciences | Young Researcher Award

Published on by Popular Engineer

Dr. Giulia Mauri | Medicine and Health Sciences | Young Researcher Award

Istituto Clinico Humanitas | Italy

Dr. Giulia Mauri is an accomplished general surgery resident in her fourth year at a leading research hospital in Milan. After earning her Medical Degree cum laude from Università degli Studi di Pavia in 2018, with Erasmus studies in Finland and France, she completed the Italian Board MD exam in 2019. Her training spans across multiple domains: general and HPB (hepato-pancreato-biliary) surgery, pancreatic surgery, upper GI, colorectal, transplant surgery, emergency & trauma, endoscopy, ultrasound, otolaryngology, and interventional radiology. She has also engaged in physician roles in intensive and sub-intensive care, as well as emergency medicine, including service during the COVID-19 pandemic. Her research output includes multiple multicenter cohort studies, technical manuscripts on surgical techniques such as anatomical segmentectomies, assessments of frailty in open abdomen surgery, and studies in gallbladder drainage methods in fragile patients. Awards include competitive fellowships (e.g. Rita Levi Montalcini), merit-based residencies, and other academic fellowships. Her research interests lie in surgical innovation, patient frailty, outcomes in emergency and trauma surgery, hepatobiliary and pancreatic surgery, and minimally invasive / robotic techniques. Her publication record comprises 7 documents, with 12 total citations and an h-index of 3. She aims to further contribute to evidence-based surgery, mentoring, and global surgical care.

Profiles : Scopus | Orcid

Featured Publications

Bunino, F. M., Zulian, D., Famularo, S., Persichetti, G. W. L., Mauri, G., & Del Fabbro, D. (2025). Open abdomen versus primary closure in nontrauma patients: A weighted analysis of a single-center experience. Journal of Trauma and Acute Care Surgery.

Procopio, F., Galvanin, J., Mauri, G., Famularo, S., Pedicini, V., Milana, F., Costa, G., & Torzilli, G. (2025). Predictive model of intrahepatic collateral vessels among hepatic veins in patients with liver tumors involving the caval confluence. Surgery.

Torzilli, G., Galvanin, J., Mauri, G., Costa, G., Branciforte, B., Milana, F., Palmisano, A., & Procopio, F. (2025). Sliced liver hepatectomy: A new type of scaffold-sparing hepatectomy for multiple bilobar colorectal liver metastases. Surgical Oncology.

Kaplan, L. J., Martinez-Casas, I., Mohseni, S., Cimino, M., Kurihara, H., Lee, M. J., Bass, G. A., Dogjani, A., Subashi, K., Doci, K., & Mauri, G. (2025). Small bowel obstruction outcomes according to compliance with the World Society of Emergency Surgery Bologna guidelines. British Journal of Surgery.

Bunino, F., Marrano, E., Carbone, F., Mauri, G., Ceolin, M., Penazzi, R., Zucchini, N., Biloslavo, A., & Kurihara, H. (2024). Clinical Frailty Score is a good predictor of postoperative mortality in patients undergoing open abdomen surgery: A multicenter retrospective cohort study. Minerva Surgery.

Avinash Kumar | Biology and Life Sciences | Best Researcher Award

Published on by Popular Engineer

Assist. Prof. Dr. Avinash Kumar | Biology and Life Sciences | Best Researcher Award

Long Island University Arnold and Marie Schwartz College of Pharmacy and Health Sciences | United States

Assist. Prof. Dr. Avinash Kumar, Ph.D., is an Assistant Professor at the Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY. With a Ph.D. in Biotechnology from the University of Pune, India, his doctoral work focused on biochemical and biophysical characterization of class II α-mannosidases. He completed postdoctoral research at the University of Mississippi Medical Center and National Center for Cell Science, India, investigating transcriptional and post-translational programs driving prostate cancer progression. His research aims to develop personalized and precision medicine strategies targeting metastatic and high-risk prostate cancer, including health disparities in African American men. Dr. Kumar utilizes high-throughput single-cell genomics, transcriptomics, and proteomics in combination with genetically engineered and xenograft mouse models, patient tissues, and complementary cell line studies. He has mentored numerous graduate, undergraduate, and Pharm.D. students, directed the Molecular Imaging Core at LIU, and actively serves on institutional committees and as a reviewer for top journals. Dr. Kumar has published 28 peer-reviewed articles, 5 book chapters, and over 20 conference abstracts, with an h-index of 17 , 873 citations, and 29 publications. He has received multiple fellowships, awards, and research grants and continues to advance translational cancer therapeutics through rigorous preclinical and mechanistic studies.

Profile : Scopus | Orcid

Featured Publications

“Reprogrammed Lipid Metabolism-Associated Therapeutic Vulnerabilities in Prostate Cancer”

“The Therapeutic Efficacy and Mechanism of Action of Gnetin C, a Natural Compound from the Melinjo Plant,     Preclinical Mouse Model of Advanced Prostate Cancer”

“AI & experimental-based discovery and preclinical IND-enabling studies of selective BMX inhibitors for       development of cancer therapeutics”

“Data from Dietary Pterostilbene for MTA1-Targeted Interception in High-Risk Premalignant Prostate Cancer”

“Supplementary Figure 1-2; Supplementary Table 1-4 from Dietary Pterostilbene for MTA1-Targeted Interception   in   High- Risk Premalignant Prostate Cancer”